Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,248) Arrow Down
Filter Results: (1,248) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,248)
    • People  (5)
    • News  (172)
    • Research  (929)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (759)

Show Results For

  • All HBS Web  (1,248)
    • People  (5)
    • News  (172)
    • Research  (929)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (759)
← Page 30 of 1,248 Results →
  • September–October 2020
  • Article

Social-Impact Efforts That Create Real Value

By: George Serafeim
Until the mid-2010s few investors paid attention to environmental, social, and governance (ESG) data—information about companies’ carbon footprints, labor policies, board makeup, and so forth. Today the data is widely used by investors. How can organizations create... View Details
Keywords: Sustainability; Sustainability Management; ESG; ESG (Environmental, Social, Governance) Performance; ESG Disclosure; ESG Disclosure Metrics; ESG Ratings; ESG Reporting; Social Impact; Impact Measurement; Social Innovation; Purpose; Corporate Purpose; Corporate Social Responsibility; Strategy; Social Enterprise; Society; Accounting; Investment; Environmental Sustainability; Climate Change; Corporate Strategy; Mission and Purpose; Corporate Social Responsibility and Impact; Financial Services Industry; Chemical Industry; Technology Industry; Consumer Products Industry; Pharmaceutical Industry; North America; Europe; Japan; Australia
Citation
Find at Harvard
Read Now
Related
Serafeim, George. "Social-Impact Efforts That Create Real Value." Harvard Business Review 98, no. 5 (September–October 2020): 38–48.
  • November 2002
  • Compilation

Four Principles of Biomedical Ethics: Definitions and Examples

By: Sandra J. Sucher
Introduces four principles of biomedical ethics, excerpted from Principles of Biomedical Ethics, Tom L. Beauchamp and James F. Childress (Oxford University Press, 2001). The principles provide a conceptual framework for the analysis and resolution of moral problems... View Details
Keywords: Framework; Moral Sensibility; Health Care and Treatment; Distribution; Problems and Challenges; Research; Emotions; Management Analysis, Tools, and Techniques; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Purchase
Related
Sucher, Sandra J. "Four Principles of Biomedical Ethics: Definitions and Examples." Harvard Business School Compilation 603-079, November 2002.
  • November 2020
  • Case

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
  • Web

Harvard Business School

for the United States Supreme Court. After HBS, he worked as an investment banker with White Weld & Co., and served as assistant treasurer for Celanese Corporation. He went on to other manufacturing companies, including Valeant View Details
  • November 2005 (Revised March 2006)
  • Case

Genentech - Capacity Planning

By: Daniel C. Snow, Steven C. Wheelwright and Alison Berkley Wagonfeld
While facilitating a complex clinical approval process over the next two to three years for a family of new cancer drugs, Genentech must develop a long-term capacity plan for a major class of new cancer products. Adding to the complexity and uncertainty is the fact... View Details
Keywords: Factories, Labs, and Plants; Growth and Development Strategy; Management Style; Management Teams; Time Management; Product; Product Development; Business Processes; Performance Capacity; Planning; Risk and Uncertainty; Complexity; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Snow, Daniel C., Steven C. Wheelwright, and Alison Berkley Wagonfeld. "Genentech - Capacity Planning." Harvard Business School Case 606-052, November 2005. (Revised March 2006.)
  • 01 Oct 2001
  • News

Guy de Chazal: Changing Focus

Fountain House board member since 1986, he speaks with deep conviction about the challenges faced by the emotionally handicapped. "With advances in pharmaceutical treatments for emotional illnesses, hospitalization is no longer the right... View Details
Keywords: Deborah Blagg
  • September 2013 (Revised August 2015)
  • Background Note

Leadership and Teaming

By: Ethan Bernstein
Small differences in the leadership of teams can have large consequences for the success of their efforts. Many initiatives fail not because of a fatal error in judgment or insufficient ideas, knowledge, motivation, or capabilities to deliver a solution. They fail... View Details
Keywords: Teams; Teaming; Leadership And Managing People; Leadership; Team Effectiveness; Team Performance; Team Design; Team Leadership; Teamwork; Team Process; Team Function; Team Launch; 60/30/10 Rule; Team Boundary; Distribution Of Leadership Authority; Self-Managed Teams; Virtual Teams; Unbounded Teams; Acts Of Leadership; Execution Teams; Decision Making Teams; Creativity Teams; Team Size; Task Design; Team Timeline; Team Roles; Team Representation; Diversity; Team Familiarity; Collective Intelligence; Team Stages Of Development; Team Coaching; Performance Pressure; X-Teams; Team Focus; Interaction; Management Teams; Managerial Roles; Management Systems; Management Style; Management Skills; Management Practices and Processes; Organizational Design; Organizational Structure; Performance Effectiveness; Performance Efficiency; Performance Productivity; Groups and Teams; Networks; Social Psychology; Behavior; Conflict and Resolution; Creativity; Social and Collaborative Networks; Satisfaction; Prejudice and Bias; Power and Influence; Personal Characteristics; Familiarity; Cognition and Thinking; Attitudes; Projects; Organizational Culture; Organizational Change and Adaptation; Leadership Development; Leadership Style; Leading Change; Knowledge Use and Leverage; Knowledge Sharing; Collaborative Innovation and Invention; Innovation and Management; Innovation Leadership; Design; Interpersonal Communication; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Asia; North and Central America; South America; Atlantic Ocean; Central Asia; Europe; Latin America; Middle East; Oceania; West Indies
Citation
Educators
Purchase
Related
Bernstein, Ethan. "Leadership and Teaming." Harvard Business School Background Note 414-033, September 2013. (Revised August 2015.)
  • 10 Aug 2015
  • Research & Ideas

New Medical Devices Get To Patients Too Slowly

While the US Food and Drug Administration has chiseled away pharmaceutical review times over the years to speed innovative drugs to market, the opposite seems to have occurred in the agency's approval of medical devices. Instead of... View Details
Keywords: by Michael Blanding; Health; Technology
  • May 2020 (Revised March 2022)
  • Case

The Coronavirus (COVID-19) Pandemic and the Global Economy (A)

By: Alberto Cavallo and Christian Godwin
In April 2020, the world struggled to contain the exponential escalation of the coronavirus (COVID-19) pandemic. Dozens of countries had imposed restrictions on travel, work, and social gatherings. A large share of the global population was under lockdowns and... View Details
Keywords: COVID-19 Pandemic; Demand and Consumers; Supply and Industry; Finance; Central Banking; Financial Markets; International Finance; Globalization; Government and Politics; Health Pandemics; Decision Making; Macroeconomics; Employment; Crisis Management; Supply Chain; Risk and Uncertainty; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Asia; China; Europe; Latin America; Africa; United States
Citation
Educators
Purchase
Related
Cavallo, Alberto, and Christian Godwin. "The Coronavirus (COVID-19) Pandemic and the Global Economy (A)." Harvard Business School Case 720-031, May 2020. (Revised March 2022.)
  • Web

2024 Reunion Presentations - Alumni

traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by allowing access to telemedicine and pharmaceuticals by mail and... View Details
  • 15 Jun 2007
  • Research & Ideas

Remembering Alfred Chandler

Chemical and Pharmaceutical Industries. In his lifetime, he produced a range of books, edited collections, and articles covering railways, management, global competition, anthracite coal, the career of Alfred P. Sloan, the nature of... View Details
Keywords: by Sean Silverthorne
  • Profile

Arjun Goyal

always at the back of my mind.” HBS stood out for two reasons. “It has a great network of alumni and professors in the biotech and pharmaceutical fields — both in world-leading corporations and start-ups,” says Arjun. “And HBS has a... View Details
Keywords: Entrepreneurship; Health Care
  • 25 Apr 2005
  • Research & Ideas

New Learning at American Home Products

pharmaceutical companies in 1984, American Home Products ranked first in sales and twenty-eighth in R&D expenditures as a percentage of sales.23 As the historian Williams Haynes noted, by the end of the 1930s, American Home Products... View Details
Keywords: by Alfred D. Chandler Jr.; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • 10 Sep 2008
  • Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
Keywords: by John Quelch; Pharmaceutical; Pharmaceutical
  • Profile

Avi Kremer

He can no longer walk, talk, or swallow, but Avi Kremer (MBA 2007) won’t let that slow down his pursuit of a cure for ALS, a progressive neurodegenerative disease. As founder of Prize4Life, the nonprofit he launched in 2006 with HBS classmates and professors, Kremer... View Details
Keywords: Health Care; Entrepreneurship

    William Steere, Jr.

    Steere was strongly devoted to making Pfizer the number one pharmaceutical company in the United States. His first task at the pharmaceutical company was to cut the 40% of its business that was unrelated to... View Details
    Keywords: Healthcare
    • Profile

    Janet Simpson Benvenuti

    Caring for her aging parents led Janet Simpson Benvenuti (MBA 1985) to launch a company that helps other families find resources that are right for their own parents’ needs. View Details
    Keywords: Health Care; Nonprofit / Government; Energy / Extractive Minerals; Manufacturing

      Charles A. Heimbold, Jr.

      Heimbold focused on Bristol-Myers Squibb’s growth and created a scientific-based, world-leading pharmaceutical company with very strong consumer franchises. Sixty-two percent of its sales come from View Details
      Keywords: Healthcare

        Richard L. Gelb

        Gelb orchestrated Bristol-Myers' successful acquisition of Squibb creating the second largest pharmaceutical company in the world. In diversifying Bristol-Myers from a personal care company to pharmaceutical... View Details
        Keywords: Healthcare
        • 24 Apr 2014
        • News

        Building a better India through business and philanthropy

        Known for understanding opportunities ahead of the curve, Ajay Piramal (AMP 110, 1992) led his family’s business away from textiles to pharmaceuticals in the 1980s. “Our guiding principle has been to build businesses that deliver... View Details
        • ←
        • 30
        • 31
        • …
        • 62
        • 63
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.